Combination therapy boosts effectiveness of telomere-directed cancer cell death
Sometimes apotential target for a drug seems very promising on paper; things areoften very different in reality. Its the case of telomerase inhibitorsto treat cancer; they are supposed to strip the "immortal" (able todivide indefinitely) aspect of cancer cells. Yet, something in the cellseems to block their function, preventing them to inhibit completelythe...DNA Recombination and Repair—A New Twist to RecA Function
Molecular motors harness the energy of ATP (or GTP, a related energy currency) and transform it into mechanical force. Well-known examples of motors include myosin and dynein, proteins that use ATP to ferry intracellular cargo along fibers made of actin or tubulin proteins. The ATP-dependent assembly of actin or tubulin fibers itself can work as a motor: for instance, the march of white blood cel...Wake Forest scientists find new combination vaccine effective against plague
Plague, a bacterium that ravaged Europe in the Middle Ages and is today one of the most feared potential agents of bio-terrorism, may have met its match, according to Wake Forest University School of Medicine scientists. Steven B. Mizel, Ph.D., principal investigator, told the American Gastroenterological Association meeting in Chicago that when mice immunized with a new combination vaccin...Combination therapy leads to partial recovery from spinal cord injury in rats
Combining partially differentiated stem cells with gene therapy can promote the growth of new "insulation" around nerve fibers in the damaged spinal cords of rats, a new study shows. The treatment, which mimics the activity of two nerve growth factors, also improves the animals' motor function and electrical conduction from the brain to the leg muscles. The finding may eventually lead to new ways...Study shows combination of immune substances to be safe
New research has shown that the immune-stimulating hormone known as interleukin-12 (IL-12) can safely be administered with interferon, another immune-system protein, as an experimental therapy for some cancers. Normally, interferon is used alone to stimulate the immune system to attack certain cancers. This strategy, a form of immunotherapy, is sometimes used to treat melanoma, advanced k...Affi-Gel 10 to 15 Combination, 2 x 25 ml each from Bio-Rad
Description:Activated affinity media for spontaneous ligand immobilization can be coupled with a ligand such as an antibody, enzyme, antigen, or receptor to create an affinity matrix of choice. Affi-Gel 10 and Affi-Gel 15 supports couple ligands via primary amines. Affi-Gel 10 gel couples neutral or basic proteins with pI from 6.5 to 11; Affi-Gel 15 gel couples acidic proteins with pI less than 6.5. This Aff...Combination Roto Shake Genie from Femto Scientific
Description:...Consensus on "Combination Therapy" for Breast Cancer
Breast cancer is the commonest cancer among women in the world. There has been some on going controversy on certain aspects of treatment modalities of this cancer. Besides surgery there are other options to treat the cancer including radiation, chemotherapy and hormonal therapy. Now at a three-day conference at the National Institutes of Health doctors have agreed to a consensus on the combinati...Drug Combinations May Boost Stroke Risk
People who combine different types of serotonin-enhancing medications, such as certain antidepressants and migraine medications, may be increasing their risk of stroke. //The study reports on three patients who developed ischemic strokes related to the use of serotonin-enhancing medications, which include certain antidepressants, anti-migraine drugs, decongestants and diet pills. Ischemic strokes...Combination therapy to treat breast cancer
The combination of two targeted drug therapies results in dramatic reduction in breast cancer cell growth in vitro, indicating a potentially powerful new approach to treating the condition.// The two drug agents – trastuzumab and ZD1839 were found to work synergistically to inhibit the action of two different growth factors receptors, HER2 and epidermal growth factor receptor (EGFR). P...Combination regime may work against prostate cancer
A recent study published in the Journal of Clinical Oncology suggests that men with advanced Prostate Cancer respond better to a combination of Vitamin D with the chemotherapy drug// Taxotere. A phase II clinical trial of 35 men treated with a combination of Taxotere and Calcitriol found that this combination regime was more effective than treatment with Taxotere alone. This was measur...Pediatric Combination Eye Garter Shield Cover and Fox Shield
Description:Includes one aluminum pediatric eye shield and one eye garter shield cover. Packaged 50 per box. White only....Combination Eye Garter Shield Cover and Fox Shield
Description:Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....Spanish HRR/Amsler Combination
Description:Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....Tango SLT and Photodisruptor Combination Laser
Description:The Laserex Tango ophthalmic laser system provides two lasers in the one system: an SLT laser and a photodisruptor for posterior capsulotomy and iridotomy. The SLT laser is a frequency-doubled Nd:YAG producing pulsed 532 nm light. The photodisruptor laser is an Nd:YAG producing 1064 nm. The appropriate laser can be easily selected and treatment by both lasers is channelled through the same delive...DGH-5100e Combination A-Scan/Pachymeter
Description:Combination A-Scan/Pachymeter with graphic display and IOL power calculation software. All A-scans and A-Scan/Pachymeter combination units include firmware module with SRKII, SRKT, Holladay Dioptimum and Binkhorst II formulas. Audible tones increase in frequency the closer you get to visual axis. Constant tone when alignment is achieved with corneal indentation. Triple tone when measurement is ob...Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - CyclacelPharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced todaythe results from two Phase II non-randomized studies of seliciclibfixed dose combinations. In one study seliciclib was given incombination with gemcitabine and cisplatin and in another withdocetaxel in patients with advanced non-small cell lung cancer(NSCLC).<p...